Results 191 to 200 of about 4,538 (283)

Analysis of clinical investigation (device) initial submissions received by the Medicines and Healthcare products Regulatory Agency between January 2022 and December 2025

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse clinical investigation‐device initial submissions received by the MHRA between January 2022 and December 2025. Methods Data on submissions were extracted from the clinical investigations unit data bank; software as medical devices were not included. The predefined primary end‐point was submission type.
Andrea Manfrin, Mark Grumbridge, Daniel Hill, Crina Cacou, Graham Warren, James Pound, Jacob George, Alejandro F. Frangi   +7 more
wiley   +1 more source

Incidental Heterotaxy Syndrome With Polysplenia and Inferior Vena Cava Agenesis Identified During Trauma Evaluation. [PDF]

Cureus
Ahmed Z, Abdallah S, Alahmed H, Akbarpoor F, Al Ozaibi L.   +4 more
europepmc   +1 more source

Heterotaxy Syndrome [PDF]

, 2020
openaire   +1 more source

Bourdieu in Aotearoa New Zealand: A systematic review of theoretical applications in educational research, 2000–2025

British Educational Research Journal, EarlyView.
Abstract This article presents the first systematic review of scholarship applying Pierre Bourdieu's theoretical framework in New Zealand educational research, drawing on 30 peer‐reviewed studies published between 2000 and 2025. Following PRISMA guidelines, studies were coded for Bourdieusian concepts applied, depth of theoretical application ...
Liuning Yang
wiley   +1 more source

From multiple spleens to absence: Insights from two cases of heterotaxy syndromes. [PDF]

Radiol Case Rep
Paudel S, Banjade RR, Sharma NK, Ghimire S, Rokaha PS.   +4 more
europepmc   +1 more source

Integrated spherical nucleic acid nanoreactor mobilizes targeted PD‐L1 proteolysis and cuproptosis for robust breast cancer immunotherapy

BMEMat, EarlyView.
This study provides an integrated spherical nucleic acid nanoreactor (denoted as AMCuD) for targeted PD‐L1 degradation and chemo‐dynamically enhanced cuproptosis to synergically elicit robust immunotherapy against the triple‐negative breast cancer (TNBC) growth, recurrence and metastasis.
Ningxi Li, Honglin Huang, Qianyi Zeng, Li Zeng, Ziman Yang, Jinyang Shen, Shun Li, Hong Yang, Yiyao Liu, Chunhui Wu   +9 more
wiley   +1 more source

The Influence of ESG Controversies on Financing Costs for European Companies: Does Culture Matter?

Business Strategy and the Environment, EarlyView.
ABSTRACT This study examines the relationship between environmental, social, and governance (ESG) controversies and corporate financing costs, focusing on the moderating effect of national culture. It analyzes European companies listed on the STOXX 600 Index from 2016 to 2023.
Souad Brinette, Marie‐Josèphe Rigobert, Slimane ED‐Dafali   +2 more
wiley   +1 more source

Management of Acute Cholecystitis in a Patient With Eisenmenger Syndrome and Abdominal Heterotaxy: A Case Report. [PDF]

Am J Case Rep
Sanders JM, Harris M, Caicedo JC, Schwulst SJ.   +3 more
europepmc   +1 more source

Do Governance Structures Drive Green Building Adoption? A Machine Learning Approach With Random Forests

Business Strategy and the Environment, EarlyView.
ABSTRACT This study examines the determinants of firms' propensity to adopt green buildings in the Euro Stoxx 300 and the S&P 500 indices, during 2012–2023. Using random forest binary classifiers, we assess the relative importance of financial, sectoral, geographic, and climate governance predictors and uncover nonlinear relationships often overlooked ...
María del Carmen Valls Martínez, José Manuel Santos‐Jaén, María Estefanía Sánchez Pacheco, Fernando José Zambrano Farías   +3 more
wiley   +1 more source